The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 1.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 40%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (15 analysts) rates it none, with a mean price target of $154.
DT Midstream Inc
DTM · the NYSE · USD · Market cap $11.6B · 588 employees
DT Midstream, Inc., together with its subsidiaries, provides integrated natural gas services in the United States.
FAIL · Does not pass the screenPrice as of 13 Nov 2026Daily close, not a live quoteLast reviewed 4 days ago
Screened 2026-11-13 · the tape above runs as of 02:01 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price119.73 USD at the 13 Nov 2026 close
- Our value readOvervalued vs our fair value, as of 13 Nov 2026
- Our regime readMarkup, as of 15 Nov 2026
- Ethical screenDoes not pass
- OptionsOpen interest leans heavily to calls (put/call 0.03)
- Last reviewed13 Nov 2026 (4 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: $93.73 to $107.79, base estimate $93.73 (screen dated 2026-11-13).
- Trend Markup
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 0.03, read 2026-11-14
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markup label.
DT Midstream Inc holds its Markup at $119.73. The statistical read favours the sellers, held for 358 days.
| Phase | Markup |
| Quantitative state | The statistical read favours the sellers, held for 358 days |
| Price at the screen | $119.73 |
| Valuation | 24.76 trailing · 22.62 forward price to earnings |
| Values screen | FAIL · score 70.0 |
| Beta | 0.74 |
Five Screens, Shown in Full
Does not pass. Debt ratio
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 33.45% | Below 33% | Interest-bearing debt is 33.5% of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 2.38% | Below 49% | Money owed to the company is 2.4% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.16% | Below 5% | Only 0.2% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Falls Short, in Plain English
DT Midstream's business is in a permissible area, but its interest-bearing debt is about 33% of the company, just over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-11-15. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when DTM's ethical verdict changes
Today DTM does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Our analysis reads Overvalued vs our fair value, as of 13 Nov 2026: it trades above our $93.73 fair value estimate, narrow competitive moat, 7.00% revenue growth.
How a fair value is estimated: discounted cash flow (DCF).
Fair value range in USD, drawn from the 2026-11-13 screen. The gold marker is the market price at the same screen. The price runs 27.7% above the base estimate.
Third-party analyst targets: 15 covering, consensus Buy. The average target sits +21% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & ProjectionsWhere our models see it going: fair-value estimate $93.73, with a range of $93.73 to $107.79, dated to the 2026-11-13 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsGas Pipelines Priced Well Beyond Fair Value
Picture the vast web of pipes carrying gas from wells to power plants and homes. DT Midstream sits in the middle of that flow, yet it trades at 145 dollars against a fair value near 99, a 32 percent premium that leaves little room for error.
The numbers do not support stretching for it. Forward earnings sit at 29 times, revenue rises at 11 percent, yet return on equity reaches only 10 percent behind a narrow moat. In a cyclical energy sector that pattern often signals peak conditions rather than a bargain, and the opportunity rating stays at none.
Energy volumes can swing sharply with weather, prices and policy. A narrow competitive edge offers limited defence when those cycles turn. Analysis, not advice.
| Forward P/E | 22.6xexpensive even after accounting for its growth |
| Trailing P/E | 24.8xa premium valuation |
| EPS, trailing | 4.59 |
| EPS, forward | 5.03 |
| Revenue growth | +7.0%slow but positive growth |
| Profit margin | 35.4%highly profitable on every dollar of sales |
| Return on equity | 9.9%a modest return on shareholder capital |
| FCF yield | 2.27% |
| Dividend yield | 2.46% |
| Debt to equity | 0.67moderate, manageable leverage |
| Current ratio | 1.16adequate liquidity, worth monitoring |
| Beta | 0.74steadier than the market |
| Short interest, float | 0.09% |
| 52-week range | 111.01 - 152.88 |
| Moat | NARROW |
| Market cap | $11.6B |
| Employees | 588 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeDTM trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 5.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 40%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (15 analysts) rates it none, with a mean price target of $154.
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 40%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (15 analysts) rates it none, with a mean price target of $154. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 40%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (15 analysts) rates it none, with a mean price target of $154. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 40%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (15 analysts) rates it none, with a mean price target of $154. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 40%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (15 analysts) rates it none, with a mean price target of $154. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 40%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (15 analysts) rates it none, with a mean price target of $154. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 2.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 40%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (15 analysts) rates it none, with a mean price target of $154. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 40%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (15 analysts) rates it none, with a mean price target of $154. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 40%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (15 analysts) rates it none, with a mean price target of $154. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- DT Midstream (DTM) Could Face a Sell-Off as the Energy Trade Unwinds Yahoo Finance · 2d ago
- Roblox downgraded, Palo Alto upgraded: Wall Street's top analyst calls Yahoo Finance · 4d ago
- What U.S. Targeted Value Portfolio (DFAT) Bought: Lululemon Leads on Nov. 5 Yahoo Finance · 8d ago
- DT Midstream Inc (DTM) (Q3 2026) Earnings Call Highlights: Raised EBITDA Guidance, $2. ... Yahoo Finance · 14d ago
- OXY or DTM: Which Is the Better Value Stock Right Now? Yahoo Finance · 14d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $145.30 | -2.3% | · | $977 | -2.3% |
| 2 months | $135.64 | +4.6% | · | $1,046 | +4.6% |
| 3 months | $134.77 | +5.3% | $0.88 | $1,060 | +6.0% |
| 6 months | $117.95 | +20.3% | $1.70 | $1,218 | +21.8% |
| 1 year | $101.48 | +39.9% | $3.34 | $1,432 | +43.2% |
| 2 years | $64.59 | +119.8% | $6.37 | $2,296 | +129.6% |
| 3 years | $43.40 | +227.1% | $9.17 | $3,482 | +248.2% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever DTM does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.